Open original FDA record ↗Recall record
- FDA identifier
- Z-0556-2016
- Company in FDA record
- Biomerieux Inc
- FDA classification date
- Dec 29, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
FDA has determined that the product requires 510(k) clearance to continue marketing/distribution in the United States.
Source facts
- Action
- The firm, Biomerieux, sent an "Urgent Product Removal Notice" dated November 23, 2015 to its consignees. The letter described the product, problem and actions to be taken. The consignees were instructed to confirm that the letter has been distributed and reviewed by all appropriate personnel, discontinue and discard any remaining inventory, store letter with your bioMerieux documentation and complete the attached Acknowledgement Form via fax to: (919) 620-3306 attention of: bioMerieux NA ComOps QA/RA. If you have any questions or concerns, please contact your local bioMrieux Clinical Customer Service organization at (800) 682-2666.
- Initiated
- 2015-11-23
- Root cause
- No Marketing Application
- Terminated
- 2016-02-24
- Distribution
- US Distribution to states of: CA, GA, IN, MA, MN, MO, NY, OH and PA.
- Recall number
- Z-0556-2016
- Recall status
- Terminated
- CDRH record ID
- 142164
- FDA classified
- 2015-12-29
- Recall event number
- 72760